Historical review requests jump fivefold

Top story

Historical Commission sees surge in reviews after zoning change

The Cambridge Historical Commission has fielded more than 340 queries since the Multifamily Housing Ordinance passed in February 2025, a fivefold increase, according to executive director Charles Sullivan. The ordinance created a multifamily zoning district across most of the city, allowing developers to build up to four stories by-right or six stories with affordable units. Sullivan said the prospect of a 45- to 70-foot building rising five feet from a property line has driven residents to seek preservation review, making the commission a de facto arbiter of the city's landscape.

Cambridge Day

BOSHUG July meetup explores cloud and AI in healthcare

The Boston Healthcare Cloud & AI Community hosts its July meetup tonight at 5:30 p.m. at the Microsoft NERD Center in Cambridge, with guest speaker Ashish Bhatia.

BOSHUG

MIT's Fab Lab hosts global digital fabrication conference

Celebrating its 25th anniversary, MIT's Fab Lab is hosting the FAB26 Conference & Symposium across MIT and Kendall Square through July 31, showcasing rapid prototyping and makerspace innovations.

Cambridge Day

Cambridge Public Library hosts virtual Death Cafe

Adults can join an open, virtual discussion about mortality hosted by the Cambridge Public Library tonight from 7 to 8:15 p.m.

Death Cafe

Outdoor STEAM Patio Project pops up at the Valente Library

Families and children are invited to hands-on science, technology, engineering, art, and math activities on the Valente Branch Library patio today from 5 to 6 p.m.

Cambridge Public Library Calendar

Harbour BioMed and Sinopharm launch global biopharma partnership

Cambridge-based Harbour BioMed announced a strategic collaboration with Sinopharm on July 27 to establish a joint innovation consortium for oncology and immunology biologics research.

Harbour BioMed

ProMIS Neurosciences hosts webinar on early Alzheimer's trial data

Cambridge-based ProMIS Neurosciences held a public webinar today at 8 a.m. ET to present six-month blinded interim data from its Phase 1b trial of Alzheimer's treatment PMN310.

BioSpace

Michael Severino takes over as CEO of Sarepta Therapeutics

Cambridge-based Sarepta Therapeutics says Michael Severino, M.D., officially becomes CEO today, succeeding retiring CEO Doug Ingram.

StreetInsider

Biogen-funded autopsy study shows positive results for ALS drug

An autopsy study published in Nature Medicine on July 27, supported by Cambridge-based Biogen, found that the drug tofersen reaches target tissues and reduces toxic SOD1 protein levels in the spinal cord.

NeurologyLive

State representative files property tax exemption bill for Cambridge

State Rep. Marjorie Decker filed a petition (Bill H.5607), with City Council approval, to let Cambridge grant a personal property tax exemption of $30,000 or less.

Massachusetts Legislature

Rock band Arranged In April to perform at The Sinclair

Alternative rock band Arranged In April headlines an all-ages concert tonight at The Sinclair in Harvard Square, with support from soap box derby, Summers in Autumn, and Stringhead.

Sinclair Cambridge

Insilico Medicine announces progress on AI-designed cancer drug

Cambridge-based Insilico Medicine announced on July 27 that first-in-human Phase 1 trial data for its AI-designed cancer drug ISM6331 has been accepted for presentation at the ESMO Congress.

PR Newswire

Junk journaling pops up at Vellucci Plaza

Cambridge Plays brings Albertine Press to Vellucci Plaza today from 4 to 6 p.m. for an outdoor junk journaling session with pens, stickers, washi, and mini journals.

City of Cambridge